Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Motor Activity 2 Breast Neoplasms 2 Brain Neoplasms 2 Uveal Melanoma 1 Suicidal Ideation 1 Skin Cancer Face 1 Polycystic Ovary Syndrome 1 Parotid Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Hyperandrogenism 1 Head and Neck Neoplasms 1 Glioblastoma 1 Disability Physical 1 Depression 1 Cancer-related Fatigue 1 Bursitis 1 Anal Intraepithelial Neoplasia 1

Interventions

Temozolomide 12 Magnetic Resonance Spectroscopy 9 Radiotherapy 6 Surveys and Questionnaires 5 Blood Specimen Collection 4 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Radiation 3 Perfusion Magnetic Resonance Imaging 2 Magnetic Resonance Imaging 2 Lomustine 2 Immunotherapy 2 Drug Therapy 2 Chemoradiotherapy 2 Amplified Fragment Length Polymorphism Analysis 2 regorafenib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 gadodiamide 1 apatinib 1 Ultrasonography 1 Trail Making Test 1 Therapies, Investigational 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Sampling Studies 1 Re-Irradiation 1 Quality of Life 1 Psychometrics 1 Proton Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Glioblastoma × Physical Examination × Clear all

NCT07409584 2026-05-18

SHINE-GLIO

University Hospital, Essen

Depression, Glioblastoma, Suicidal Ideation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡